Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Anebulo Pharmaceuticals (ANEB)
NASDAQ:ANEB
RESEARCH TOOLSreports
Holding ANEB?
Track your performance easily
ANEB Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.25 - $3.30
Previous Close$1.5
Volume1.92K
Average Volume (3M)8.83K
Market Cap
$38.38M
Enterprise Value$37.50M
Total Cash (Recent Filing)$1.40M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.06
Next Earnings
Feb 07, 2025EPS Estimate
-$0.08Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.31
Shares Outstanding25,933,217
10 Day Avg. Volume8,071
30 Day Avg. Volume8,833
Standard Deviation0.23
R-Squared0.05
Alpha-0.00317
Financial Highlights & Ratios
Price to Book (P/B)21.71
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-5.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-4.83
Forecast
1Y Price Target
$8.00Price Target Upside440.54% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Anebulo Pharmaceuticals News
PremiumCompany Announcements
Anebulo Pharmaceuticals Advances Cannabis Toxicity Solutions
PremiumCompany Announcements
Anebulo Pharmaceuticals Updates Corporate Presentation
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ANEB FAQ
What was Anebulo Pharmaceuticals’s price range in the past 12 months?
Anebulo Pharmaceuticals lowest stock price was $1.25 and its highest was $3.30 in the past 12 months.
What is Anebulo Pharmaceuticals’s market cap?
Currently, no data Available
When is Anebulo Pharmaceuticals’s upcoming earnings report date?
Anebulo Pharmaceuticals’s upcoming earnings report date is Feb 07, 2025 which is in 77 days.
How were Anebulo Pharmaceuticals’s earnings last quarter?
Anebulo Pharmaceuticals released its earnings results on Nov 13, 2024. The company reported -$0.08 earnings per share for the quarter, missing the consensus estimate of -$0.05 by -$0.03.
Is Anebulo Pharmaceuticals overvalued?
According to Wall Street analysts Anebulo Pharmaceuticals’s price is currently Undervalued.
Does Anebulo Pharmaceuticals pay dividends?
Anebulo Pharmaceuticals does not currently pay dividends.
What is Anebulo Pharmaceuticals’s EPS estimate?
Anebulo Pharmaceuticals’s EPS estimate is -$0.08.
How many shares outstanding does Anebulo Pharmaceuticals have?
Anebulo Pharmaceuticals has 25,933,216 shares outstanding.
What happened to Anebulo Pharmaceuticals’s price movement after its last earnings report?
Anebulo Pharmaceuticals reported an EPS of -$0.08 in its last earnings report, missing expectations of -$0.05. Following the earnings report the stock price went down -1.935%.
Which hedge fund is a major shareholder of Anebulo Pharmaceuticals?
Currently, no hedge funds are holding shares in ANEB
---
Anebulo Pharmaceuticals Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-30.23%
12-Months-Change
Fundamentals
Return on Equity
-154.87%
Trailing 12-Months
Asset Growth
-72.72%
Trailing 12-Months
Company Description
Anebulo Pharmaceuticals
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company. It is developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The lead product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.
---
ANEB Stock 12 Month Forecast
Average Price Target
$8.00
▲(440.54% Upside)
Technical Analysis
Best Analysts Covering ANEB
1 Year
1 Year Success Rate
1/5 ratings generated profit
1 Year Average Return
-22.46%
reiterated a buy rating 2 months ago
Copying Robert Wasserman's trades and holding each position for 1 Year would result in 20.00% of your transactions generating a profit, with an average return of -22.46% per trade.
---